Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: Prediction of the efficacy of β-blockade therapy and interest of unilateral adrenalectomy

Endocrine Journal

Volumn 56, Issue 7, 2009, Pages 867-877

  Mazzuco, Tânia L ^a   Chaffanjon, Philippe ^a   Martinie, Monique ^a   Sturm, Nathalie ^a   Chabre, Olivier ^a  

^a HÔPITAL MICHALLON   (France)

Author keywords

Adrenal glands; Adrenalectomy; Adrenergic antagonists; Cushing's syndrome; Hyperplasia

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN RECEPTOR; ATENOLOL; BETA ADRENERGIC RECEPTOR; CHORIONIC GONADOTROPIN RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GONADORELIN DERIVATIVE; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; PROPRANOLOL; SEROTONIN 4 RECEPTOR; SOMATOSTATIN;

ADRENAL HYPERPLASIA; ADRENAL INSUFFICIENCY; ADRENALECTOMY; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CUSHING SYNDROME; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPOGLYCEMIA; RAYNAUD PHENOMENON;

ADRENAL GLANDS; ADRENALECTOMY; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; HYPERPLASIA; MIDDLE AGED; POSTURE; PROPRANOLOL; TREATMENT OUTCOME; VASOPRESSINS;

EID: 70350656083     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-370     Document Type: Article

References (44)

1. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A (2000) Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 85: 3531-3536.
2. Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A (2001) Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 86: 5534-5540.
3. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J (2004) Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15: 375-382.
4. Mazzuco TL, Chabre O, Feige JJ, Thomas M (2006) Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J Clin Endocrinol Metab 91: 196-203.
5. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M (2006) Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147: 782-790.
6. Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P (2009) Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf) in press.
7. Croughs RJ, Zelissen PM, van Vroonhoven TJ, Hofland LJ, N'Diaye N, Lacroix A, de Herder WW (2000) GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Clin Endocrinol (Oxf) 52: 235-240.
8. th International Congress of Endocrinology, p 99 (Abstract).
9. Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thieblot P, Schlienger JL, Luton JP, Bertagna X, Bertherat J (2002) The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab 87: 1980-1985.
10. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R, et al. (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 327: 974-980.
11. Lacroix A, Ndiaye N, Tremblay J, Hamet P (2001) Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22: 75-110.
12. Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, Narboni G, Mahoudeau J, Saez JM (1998) Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. J Clin Endocrinol Metab 83: 4514-4519.
13. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A (1999) Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome. J Clin Endocrinol Metab 84: 2616-2622.
14. Pralong FP, Gomez F, Guillou L, Mosimann F, Franscella S, Gaillard RC (1999) Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion. J Clin Endocrinol Metab 84: 3817-3822.
15. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J (1992) Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327: 981-986.
16. Swords FM, Aylwin S, Perry L, Arola J, Grossman AB, Monson JP, Clark AJ (2005) The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease? J Clin Endocrinol Metab 90: 3009-3016.
17. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H (2005) In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 90: 1302-1310.
18. Albiger NM, Occhi G, Mariniello B, Iacobone M, Favia G, Fassina A, Faggian D, Mantero F, Scaroni C (2007) Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results. Eur J Endocrinol 157: 771-778.
19. Imohl M, Koditz R, Stachon A, Muller KM, Nicolas V, Pfeilschifter J, Krieg M (2002) [Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy]. Med Klin (Munich) 97: 747-753.
20. th Annual Meeting, P25-22 (Abstract).
21. th Annual Meeting, P3-592 (Abstract).
22. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P (1997) Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 337: 1429-1434.
23. Miyamura N, Tsutsumi A, Senokuchi H, Nakamaru K, Kawashima J, Sakai K, Taguchi T, Tokunaga H, Nishida K, Uehara M, Sakakida M, Araki E (2003) A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland. Endocr J 50: 333-340.
24. Miyamura N, Taguchi T, Murata Y, Taketa K, Iwashita S, Matsumoto K, Nishikawa T, Toyonaga T, Sakakida M, Araki E (2002) Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine 19: 319-326.
25. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ, de Herder WW (2003) Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J Clin Endocrinol Metab 88: 230-237.
26. th Annual Meeting, P3-673 (Abstract).
27. Lacroix A, Hamet P, Boutin JM (1999) Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 341: 1577-1581.
28. Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, Shibata T, Suwa T, Ishizuka T, Yasuda K (1998) In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 49: 403-409.
29. Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, Suwa T, Hanafusa J, Daido H, Morita H, Yasuda K (2002) Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 87: 5706-5713.
30. Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H (1995) Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin- independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 80: 2336-2341.
31. Iida K, Kaji H, Matsumoto H, Okimura Y, Abe H, Fujisawa M, Kamidono S, Chihara K (1997) Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clin Endocrinol (Oxf) 47: 739-745.
32. Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, Schiffrin EL, Hamet P (1997) Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 82: 2414-2422.
33. Yamakita N, Murai T, Ito Y, Miura K, Ikeda T, Miyamoto K, Onami S, Yoshida T (1997) Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Intern Med 36: 536-542.
34. Lee S, Hwang R, Lee J, Rhee Y, Kim DJ, Chung UI, Lim SK (2005) Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf) 63: 625-630.
35. Vezzosi D, Cartier D, Regnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H, Caron P (2007) Familial adrenocorticotropin- independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 156: 21-31.
36. Suzuki S, Uchida D, Koide H, Tanaka T, Noguchi Y, Saito Y, Tatsuno I (2008) Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s). Peptides.
37. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, Kuhn JM, Lacroix A, Tabarin A, Young J, Vaudry H, Lefebvre H (2003) Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 88: 248-254.
38. Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, Serio M, Peri A (2003) Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. J Clin Endocrinol Metab 88: 4616-4622.
39. Swain JM, Grant CS, Schlinkert RT, Thompson GB, vanHeerden JA, Lloyd RV, Young WF (1998) Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg 133: 541-545; discussion 545-546.
40. Lacroix A, Hamet P, Boutin JM (1999) Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. The Endocrinologist 9: 9-15.
41. Lamas C, Alfaro JJ, Lucas T, Lecumberri B, Barcelo B, Estrada J (2002) Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: Long-term follow-up of four cases. Eur J Endocrinol 146: 237-240.
42. Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ, Chabre O (2007) Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing β-blocker-sensitive Cushing's syndrome. Arq Bras Endocrinol Metabol 51: 1452-1462.
43. Lefebvre H, Duparc C, Chartrel N, Jegou S, Pellerin A, Laquerriere A, Ivell R, Vaudry H, Kuhn JM (2003) Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 88: 3035-3042.
44. Mazzuco TL, Bourdeau I, Lacroix A (2009) Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 16: 203-210.